153 related articles for article (PubMed ID: 37553957)
1. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
[TBL] [Abstract][Full Text] [Related]
3. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.
Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK
Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
7. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
8. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
[TBL] [Abstract][Full Text] [Related]
12. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR
Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
Sieczkowski M; Gibas A; Bronk M; Matuszewski M
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
17. Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.
Siyez E
Medicine (Baltimore); 2021 Oct; 100(41):e27539. PubMed ID: 34731153
[TBL] [Abstract][Full Text] [Related]
18. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
